Morning Market Movers
April 22, 2014 at 09:43 AM EDT
Revance Therapeutics (NASDAQ: RVNC) shares gained 21.91% to $34.89 after the company reported positive results from the RT002 Phase 1/2 ...
Morning Market MoversApril 22, 2014 at 09:43 AM EDT
Revance Therapeutics (NASDAQ: RVNC) shares gained 21.91% to $34.89 after the company reported positive results from the RT002 Phase 1/2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|